HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada-Only Import Plan “Feasible,” HHS Says: Savings Would Be “Modest”

Executive Summary

The Bush Administration would accept a Canada-only importation program that focuses solely on high volume brands, HHS Secretary Thompson and Commerce Secretary Donald Evans indicated in a Dec. 21 letter to Congress
Advertisement

Related Content

HHS builds senior staff
Reimportation Bill From Dorgan/Snowe Includes User Fees To Fund Oversight
HHS Nominee Pledges To Protect FDA “Brand”; Commissioner Coming Soon
Global Price Controls Cost Rx Industry $18-$27 Bil. A Year, Commerce Says
Global Price Controls Cost Rx Industry $18-$27 Bil. A Year, Commerce Says
HHS Nominee Leavitt Leaves Medicare Rx Implementation Team Intact
Drug Import Task Force Seeks Health Canada Input As It Prepares Final Report
Drug Import Task Force Seeks Health Canada Input As It Prepares Final Report
Senate Drug Import Bill Would Require Notice Of Manufacturing Changes
FDA Rx Import Task Force Will Hold Inaugural Stakeholder Meeting March 19

Topics

Advertisement
UsernamePublicRestriction

Register

PS045175

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel